Director Stejbach Mark made one open market purchase of Indivior Pharmaceuticals ($INDV) shares in the last year, totaling $27,429 on January 5, 2026. This ranks 3,519th out of 4,983 insiders in our database, well below the average purchase of $1.46 million across 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Stejbach Mark | Director | A | Common Stock | 6518 | $0.00 | 27,087.0000 | 125,000,000 | 31.69% | 0.01% |
| Jan. 26, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Stejbach Mark | Director | A | Common Stock | 3722 | $0.00 | 20,569.0000 | 125,000,000 | 22.09% | 0.00% |
| Jan. 5, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Stejbach Mark | Director | P | Ordinary Shares | 775 | $35.39 | 16,847.0000 | 125,000,000 | 4.82% | 0.00% |